{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:47:07Z","timestamp":1791967627828,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11540-1","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:15:20Z","timestamp":1743862520000},"page":"6516-6526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["ESR Essentials: assessing the radiological response of liver metastases to systemic therapy\u2014practice recommendations by the European Society of Gastrointestinal and Abdominal Radiology"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3243-6699","authenticated-orcid":false,"given":"Marco","family":"Dioguardi Burgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"11540_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"11540_CR2","doi-asserted-by":"publisher","unstructured":"Zamboni GA, Cappello G, Caruso D et al (2024) ESR Essentials: response assessment criteria in oncologic imaging-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-11006-w","DOI":"10.1007\/s00330-024-11006-w"},{"key":"11540_CR3","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.jhepr.2020.100100","volume":"2","author":"J Gregory","year":"2020","unstructured":"Gregory J, Dioguardi Burgio M, Corrias G et al (2020) Evaluation of liver tumour response by imaging. JHEP Rep 2:100100. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100100","journal-title":"JHEP Rep"},{"key":"11540_CR4","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18:e143\u2013e152. https:\/\/doi.org\/10.1016\/S1470-2045(17)30074-8","journal-title":"Lancet Oncol"},{"key":"11540_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00306-8","volume":"9","author":"C-C Ko","year":"2021","unstructured":"Ko C-C, Yeh L-R, Kuo Y-T, Chen J-H (2021) Imaging biomarkers for evaluating tumor response: RECIST and beyond. Biomark Res 9:52. https:\/\/doi.org\/10.1186\/s40364-021-00306-8","journal-title":"Biomark Res"},{"key":"11540_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejca.2015.10.014","volume":"53","author":"SH Yoon","year":"2016","unstructured":"Yoon SH, Kim KW, Goo JM et al (2016) Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 53:5\u201315. https:\/\/doi.org\/10.1016\/j.ejca.2015.10.014","journal-title":"Eur J Cancer"},{"key":"11540_CR7","doi-asserted-by":"publisher","unstructured":"Kim GY, Jalali A, Gard G et al (2024) Initial assessment of resectability of colorectal cancer liver metastases versus clinical outcome. Clin Colorectal Cancer. https:\/\/doi.org\/10.1016\/j.clcc.2024.10.001","DOI":"10.1016\/j.clcc.2024.10.001"},{"key":"11540_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ejso.2023.01.011","volume":"49","author":"KF Kuhlmann","year":"2023","unstructured":"Kuhlmann KF, Tufo A, Kok NF et al (2023) Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging. Eur J Surg Oncol 49:1016\u20131022. https:\/\/doi.org\/10.1016\/j.ejso.2023.01.011","journal-title":"Eur J Surg Oncol"},{"key":"11540_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1159\/000510445","volume":"111","author":"C Dromain","year":"2021","unstructured":"Dromain C, Sundin A, Najran P et al (2021) Tumor growth rate to predict the outcome of patients with neuroendocrine tumors: performance and sources of variability. Neuroendocrinology 111:831\u2013839. https:\/\/doi.org\/10.1159\/000510445","journal-title":"Neuroendocrinology"},{"key":"11540_CR10","doi-asserted-by":"publisher","first-page":"S834","DOI":"10.1016\/j.hpb.2021.08.341","volume":"23","author":"NJ Wesdorp","year":"2021","unstructured":"Wesdorp NJ, Bolhuis K, Roor J et al (2021) Total tumor volume response versus RECIST upon systemic treatment in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 23:S834. https:\/\/doi.org\/10.1016\/j.hpb.2021.08.341","journal-title":"HPB (Oxford)"},{"key":"11540_CR11","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1148\/rg.220056","volume":"42","author":"K Ozaki","year":"2022","unstructured":"Ozaki K, Higuchi S, Kimura H, Gabata T (2022) Liver metastases: correlation between imaging features and pathomolecular environments. Radiographics 42:1994\u20132013. https:\/\/doi.org\/10.1148\/rg.220056","journal-title":"Radiographics"},{"key":"11540_CR12","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1245\/s10434-012-2335-1","volume":"19","author":"GA Poultsides","year":"2012","unstructured":"Poultsides GA, Bao F, Servais EL et al (2012) Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. Ann Surg Oncol 19:2797\u20132804. https:\/\/doi.org\/10.1245\/s10434-012-2335-1","journal-title":"Ann Surg Oncol"},{"key":"11540_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2214\/ajr.179.4.1791059","volume":"179","author":"MYM Chen","year":"2002","unstructured":"Chen MYM, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (Imatinib Mesylate). AJR Am J Roentgenol 179:1059\u20131062. https:\/\/doi.org\/10.2214\/ajr.179.4.1791059","journal-title":"AJR Am J Roentgenol"},{"key":"11540_CR14","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.3748\/wjg.v29.i36.5180","volume":"29","author":"C Maino","year":"2023","unstructured":"Maino C, Vernuccio F, Cannella R et al (2023) Liver metastases: the role of magnetic resonance imaging. World J Gastroenterol 29:5180. https:\/\/doi.org\/10.3748\/wjg.v29.i36.5180","journal-title":"World J Gastroenterol"},{"key":"11540_CR15","doi-asserted-by":"publisher","first-page":"110810","DOI":"10.1016\/j.ejrad.2023.110810","volume":"163","author":"T Sobeh","year":"2023","unstructured":"Sobeh T, Inbar Y, Apter S et al (2023) Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC\u2014a systematic review and meta-analysis. Eur J Radiol 163:110810. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110810","journal-title":"Eur J Radiol"},{"key":"11540_CR16","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1007\/s00330-018-5331-4","volume":"28","author":"HMC Cheung","year":"2018","unstructured":"Cheung HMC, Karanicolas PJ, Hsieh E et al (2018) Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy. Eur Radiol 28:3505\u20133512. https:\/\/doi.org\/10.1007\/s00330-018-5331-4","journal-title":"Eur Radiol"},{"key":"11540_CR17","doi-asserted-by":"publisher","first-page":"W1060","DOI":"10.2214\/AJR.11.6459","volume":"197","author":"P Boonsirikamchai","year":"2011","unstructured":"Boonsirikamchai P, Asran MA, Maru DM et al (2011) CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol 197:W1060\u2013W1066. https:\/\/doi.org\/10.2214\/AJR.11.6459","journal-title":"AJR Am J Roentgenol"},{"key":"11540_CR18","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1001\/jama.2009.1755","volume":"302","author":"YS Chun","year":"2009","unstructured":"Chun YS, Vauthey J-N, Boonsirikamchai P et al (2009) Association of computed tomography morphological criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA J Am Med Assoc 302:2338\u20132344. https:\/\/doi.org\/10.1001\/jama.2009.1755","journal-title":"JAMA J Am Med Assoc"},{"key":"11540_CR19","doi-asserted-by":"publisher","first-page":"e210105","DOI":"10.1148\/rycan.210105","volume":"4","author":"NJ Wesdorp","year":"2022","unstructured":"Wesdorp NJ, Kemna R, Bolhuis K et al (2022) Interobserver variability in CT-based morphologic tumor response assessment of colorectal liver metastases. Radiol Imaging Cancer 4:e210105. https:\/\/doi.org\/10.1148\/rycan.210105","journal-title":"Radiol Imaging Cancer"},{"key":"11540_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","volume":"25","author":"H Choi","year":"2007","unstructured":"Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol Off J Am Soc Clin Oncol 25:1753\u20131759. https:\/\/doi.org\/10.1200\/JCO.2006.07.3049","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"11540_CR21","doi-asserted-by":"publisher","first-page":"W15","DOI":"10.2214\/AJR.12.9498","volume":"201","author":"AB Shinagare","year":"2013","unstructured":"Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH (2013) Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol 201:W15\u2013W28. https:\/\/doi.org\/10.2214\/AJR.12.9498","journal-title":"AJR Am J Roentgenol"},{"key":"11540_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/CAD.0000000000000726","volume":"30","author":"Zhou","year":"2019","unstructured":"Zhou Y, Zhang J, Dan Pu J et al (2019) Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer. Anticancer Drugs 30:195. https:\/\/doi.org\/10.1097\/CAD.0000000000000726","journal-title":"Anticancer Drugs"},{"key":"11540_CR23","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/j.jviscsurg.2012.03.002","volume":"149","author":"P Goyer","year":"2012","unstructured":"Goyer P, Benoist S, Juli\u00e9 C et al (2012) Complete calcification of colorectal liver metastases on imaging after chemotherapy does not indicate sterilization of disease. J Visc Surg 149:e271\u2013e274. https:\/\/doi.org\/10.1016\/j.jviscsurg.2012.03.002","journal-title":"J Visc Surg"},{"key":"11540_CR24","first-page":"1546","volume":"9","author":"Y Ma","year":"2019","unstructured":"Ma Y, Wang Q, Dong Q et al (2019) How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy. Am J Cancer Res 9:1546\u20131553","journal-title":"Am J Cancer Res"},{"key":"11540_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13244-020-00904-4","volume":"11","author":"L Paulatto","year":"2020","unstructured":"Paulatto L, Burgio MD, Sartoris R et al (2020) Colorectal liver metastases: radiopathological correlation. Insights Imaging 11:99. https:\/\/doi.org\/10.1186\/s13244-020-00904-4","journal-title":"Insights Imaging"},{"key":"11540_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.17998\/jlc.2023.11.05","volume":"24","author":"H Kim","year":"2023","unstructured":"Kim H, Roh TH, Lee JS et al (2023) Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy. J Liver Cancer 24:113\u2013117. https:\/\/doi.org\/10.17998\/jlc.2023.11.05","journal-title":"J Liver Cancer"},{"key":"11540_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/1752-1947-4-382","volume":"4","author":"Y Tomimaru","year":"2010","unstructured":"Tomimaru Y, Sasaki Y, Yamada T et al (2010) Liver metastasis originating from colorectal cancer with macroscopic portal vein tumor thrombosis: a case report and review of the literature. J Med Case Reports 4:382. https:\/\/doi.org\/10.1186\/1752-1947-4-382","journal-title":"J Med Case Reports"},{"key":"11540_CR28","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1007\/s00261-019-02193-y","volume":"44","author":"F Vernuccio","year":"2019","unstructured":"Vernuccio F, Dioguardi Burgio M, Barbiera F et al (2019) CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 44:3312\u20133324. https:\/\/doi.org\/10.1007\/s00261-019-02193-y","journal-title":"Abdom Radiol (NY)"},{"key":"11540_CR29","doi-asserted-by":"publisher","first-page":"679163","DOI":"10.3389\/fonc.2021.679163","volume":"11","author":"D Gopalakrishnan","year":"2021","unstructured":"Gopalakrishnan D, Shajihan A, Purysko AS, Abraham J (2021) Pseudocirrhosis in breast cancer\u2014experience from an academic cancer center. Front Oncol 11:679163. https:\/\/doi.org\/10.3389\/fonc.2021.679163","journal-title":"Front Oncol"},{"key":"11540_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11604-023-01505-z","volume":"42","author":"S Ichikawa","year":"2024","unstructured":"Ichikawa S, Goshima S (2024) Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders. Jpn J Radiol 42:235\u2013245. https:\/\/doi.org\/10.1007\/s11604-023-01505-z","journal-title":"Jpn J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:03:15Z","timestamp":1757498595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["11540"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11540-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Marco Dioguardi Burgio.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}